Skip to content
Tenfell
Upcoming
Published 10 Dec 2018

Clone Lentiviral Particles or equivalent

Medicines and Healthcare products Regulatory Agency · United Kingdom

Key facts

Engagement closes
28 Dec 2018
Buyer type
Central government

Description

The Agency requires to purchase specified Clone Lentiviral Particles or equivalent.

An over view of the requirement is: "The project is based on genetic modification of macrophage cell lines with two tagged genes with lentiviral particles such as - 1. Sp110 (NM_175397) Mouse Tagged ORF Clone Lentiviral Particle and 2, Arl8b (NM_026011) Mouse Tagged ORF Clone Lentiviral Particle. We would like to perform a proof of concept theory in-vitro for pathogens of our interest. Ideally, we are planning to order reagents middle of January 2018 and in-vitro work would last for 2-3 months. If the proof-of-concept study looks promising we are planning to order more plasmids and perform more in-vitro experiments."

Potential suppliers if they feel they can meet the requirement should email [email protected] to register an interest.

If no submissions of potential interest are received by close of play 28 December 2018, it is then intended to perform a direct award without competition to the sole supplier we believe can deliver this requirement.

Categories (CPV)

Similar open tenders

About Medicines and Healthcare products Regulatory Agency

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.